On July 21, 2025, Autonomix Medical, Inc. entered an agreement to reduce the exercise price of existing warrants from $1.723 to as low as $0.001, allowing the purchase of 855,000 shares and generating approximately $2.5 million in proceeds. Following these transactions, the total shares outstanding will be 4,877,625.